Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study.
about
Glucagon-like peptide-1 analogues - an efficient therapeutic option for the severe insulin resistance of lipodystrophic syndromes: two case reportsInvestigational glucagon-like peptide-1 agonists for the treatment of obesity.GLP-1 receptor agonists in the treatment of polycystic ovary syndrome.Centrally Acting Agents for Obesity: Past, Present, and Future
P2860
Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Genetic variability in GLP-1 r ...... omen with PCOS: a pilot study.
@en
Genetic variability in GLP-1 r ...... omen with PCOS: a pilot study.
@nl
type
label
Genetic variability in GLP-1 r ...... omen with PCOS: a pilot study.
@en
Genetic variability in GLP-1 r ...... omen with PCOS: a pilot study.
@nl
prefLabel
Genetic variability in GLP-1 r ...... omen with PCOS: a pilot study.
@en
Genetic variability in GLP-1 r ...... omen with PCOS: a pilot study.
@nl
P2093
P2860
P1476
Genetic variability in GLP-1 r ...... omen with PCOS: a pilot study.
@en
P2093
Andrej Janež
Boštjan Pirš
Katja Goričar
Mojca Jensterle
Vita Dolžan
P2860
P2888
P304
P356
10.1007/S00228-015-1868-1
P577
2015-05-21T00:00:00Z